Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1985-12-20
1987-11-03
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546 67, 546 68, 546 69, A61K 3148, C07D45704
Patent
active
047043954
ABSTRACT:
Cyclic ether esters of 1-substituted-6-C.sub.1-4 straight chain alkyl (or allyl)ergoline-8.beta.-carboxylic acid, useful as 5HT receptor antagonists.
REFERENCES:
patent: 3113133 (1963-12-01), Hoffmann et al.
patent: 3183234 (1965-05-01), Garbrecht et al.
patent: 3228941 (1966-01-01), Bernardi et al.
patent: 3249617 (1966-05-01), Hofmann et al.
patent: 3580916 (1971-05-01), Garbrecht
patent: 4230859 (1980-10-01), Rucman
Cohen et al., J.P.E.T., 227, 327 (1983) (Cohen I).
Cohen et al., ibid, 232, 770 (1984) (Cohen II).
Lemberger et al., Life Sci., 35, 71 (1984).
Cohen et al., Drug Dev. Res., 5, 313 (1985) (Cohen IV).
Hingten et al., Abstract 37.4, Soc. for Neurosci. (13th Annual Meeting, Nov., 1983).
Garbrecht William L.
Marzoni Gifford P.
Barclay Bruce J.
Daus Donald G.
Eli Lilly and Company
Shen Cecilia
Whitaker Leroy
LandOfFree
Cyclic ether esters of 2-substituted-6-(substituted and unsubsti does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclic ether esters of 2-substituted-6-(substituted and unsubsti, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclic ether esters of 2-substituted-6-(substituted and unsubsti will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1674532